Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus delayed sacubitril/valsartan after primary PCI in acute myocardial infarction
ChiCTR2100051979Phase 4Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sacubitril + valsartan in myocardial infarction (MI) (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: Left ventricular end-diastolic volume index, Left ventricular end-systolic volume index and 7 more. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2100051979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051979.